Navigation

    Forum

    • Register
    • Login
    • Search
    • Categories
    • Recent
    • Popular
    • Users
    • Groups

    500 - Can you advise on PAAB's role/interpretation of 'drug delivery system' advertising? Examples wold be prescription drug inhalers, injectors, etc. Would advertisements focused solely on the delivery system/technology be exempt from PAAB (perhaps as a medical device), or seen as an extension of drug advertising (and reviewed in the same manner)?

    FYI post-approval change/preclearance exemption/what requires review/PAAB scope
    1
    1
    254
    Loading More Posts
    • Oldest to Newest
    • Newest to Oldest
    • Most Votes
    Reply
    • Reply as topic
    Log in to reply
    This topic has been deleted. Only users with topic management privileges can see it.
    • Jennifer Carroll
      Jennifer Carroll last edited by

      Class I, II, III, and IV medical devices are exempt from the provisions of the PAAB code (see sections 1 & 11 of the code). Claims in HCP advertising about drug delivery systems which are not classified as a medical device are subject to the PAAB code provisions (including the need for fair balance, evidence, clarity…etc.). Refer to the Medical Devices Active Licence Listing (MDALL) on the Health Canada website for Class II, III, and IV devices. You could also refer to the Medical Device Regulations (MDR) on the Government of Canada Justice Laws Website for provisions relating to the classification system.

      1 Reply Last reply Reply Quote 0
      • First post
        Last post